20/20 GeneSystems

📍 Rockville, United States🗓 Founded 2000👥 28 employees💰 Last funded Dec 2024
Research Services🌐 2020gene.com
Website LinkedIn
20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. Our headquarters are in the heart of the biotechnology corridor in Rockville, Maryland in close proximity to the National Institutes of Health with which we have extensive collaborations. 20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer. These tests generally fall into two categories: Personalized Medicine: Our patented platform technology for measuring biomarkers in tumors is highly unique in that it combines the visual advantages of classical pathology with the multiplex capabilities needed as a result of genomics and proteomics. This technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer. Early detection of lung cancer: 20/20 is developing a blood test for the early detection of lung cancer. This product will be used for screening smokers and former smokers to pre-select or enrich the patient population to receive annual CT scanning long before the disease becomes symptomatic. Biological Detection: 20/20 is on the leading edge of developing technologies to help in the detection of biological toxins.
10
Total investors
0
Early stage
0
Mid stage
0
Late stage
2000
Founded

Investors

10 investors
All
Early stage
Mid stage
Late stage
Investor geography5 countries
United States
5
United Kingdom
2
Denmark
1
Italy
1
Brazil
1
Investor activity2017–2024 · investors recorded per year
201712018220194202012021120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in 20/20 GeneSystems?
20/20 GeneSystems has 10 investors on record on gritt.io.
When did 20/20 GeneSystems last raise funding?
The most recent investment in 20/20 GeneSystems recorded on gritt.io was in December 2024.
When was 20/20 GeneSystems founded?
20/20 GeneSystems was founded in 2000.
What industry is 20/20 GeneSystems in?
20/20 GeneSystems operates in Research Services. Find similar Research Services investors on gritt.io.
Where is 20/20 GeneSystems based?
20/20 GeneSystems is headquartered in Rockville, United States.